{"id":34546,"date":"2025-07-15T08:00:00","date_gmt":"2025-07-15T06:00:00","guid":{"rendered":"https:\/\/ggba.swiss\/?p=34546"},"modified":"2025-07-15T16:05:31","modified_gmt":"2025-07-15T14:05:31","slug":"compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/","title":{"rendered":"Compremium launches human study for non-invasive thyroid cancer diagnostic"},"content":{"rendered":"\n

Compremium<\/a> has initiated its first-in-human clinical study to assess a novel, non-invasive diagnostic device for thyroid nodules. The study, conducted in collaboration with Bern University Hospital (Inselspital<\/a>), aims to evaluate whether measuring tissue compressibility can improve clinical decision-making in thyroid cancer diagnostics.<\/p>\n\n\n\n

The trial targets patients with Bethesda IV thyroid nodules, a group with an intermediate risk of malignancy, for whom current diagnostic methods often fail to provide clear guidance. Many of these patients undergo surgery as a precaution, though only 25% to 40% of nodules are ultimately found to be cancerous. By offering a more precise, non-invasive assessment, Compremium\u2019s device could help reduce the number of unnecessary thyroidectomies.<\/p>\n\n\n\n

Led by a multidisciplinary team including Prof. Marco Caversaccio, Dr. Urs Borner, and Dr. Samuel Tschopp, the 18-month study will enroll up to 30 adult patients scheduled for surgery. These patients will undergo additional compressibility testing using Compremium\u2019s CPMX2 system, which enables real-time visualization of tissue stiffness.<\/p>\n\n\n\n

Thyroid nodules affect up to two-thirds of adults, but fewer than 5% are malignant. Fine needle aspiration, the current diagnostic standard, is limited in its ability to classify indeterminate nodules. \u201cThis new technology might help us make more accurate and individualized clinical decisions,\u201d said Dr. Borner.<\/p>\n\n\n\n

Promise beyond thyroid care<\/h4>\n\n\n\n

Compremium\u2019s proprietary platform integrates ultrasound imaging with pressure sensing to provide a real-time picture of tissue compressibility\u2014malignant tissue generally being firmer than benign. Already FDA-cleared for other applications, the technology has been validated in over 40 clinical studies and shows potential across more than 30 medical indications.<\/p>\n\n\n\n

\u201cThis study allows us to explore a critical application of our technology,\u201d said Vincent Baumann, CEO of Compremium. \u201cWe believe this approach could significantly improve how thyroid nodules are evaluated and guide treatment decisions more effectively.\u201d<\/p>\n\n\n\n

If successful, the study could pave the way for broader use of Compremium\u2019s device in oncology and other diagnostic domains. The trial is registered in the Human Research Switzerland database.<\/p>\n","protected":false},"excerpt":{"rendered":"

Bern-based medtech Compremium is testing its compressibility-based device in patients with thyroid nodules to improve diagnostic precision and reduce unnecessary surgeries.<\/p>\n","protected":false},"author":6,"featured_media":34547,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[908,930,890,883],"class_list":["post-34546","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-diagnostic","tag-digital-health","tag-healthcare","tag-oncology"],"acf":[],"yoast_head":"\nCompremium launches study for thyroid cancer diagnostic | GGBa<\/title>\n<meta name=\"description\" content=\"Compremium is testing its compressibility-based device in patients with thyroid nodules to improve diagnostic precision.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Compremium launches study for thyroid cancer diagnostic | GGBa\" \/>\n<meta property=\"og:description\" content=\"Compremium is testing its compressibility-based device in patients with thyroid nodules to improve diagnostic precision.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-15T06:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-15T14:05:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/07\/Compremium-Device-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2360\" \/>\n\t<meta property=\"og:image:height\" content=\"1622\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Compremium launches human study for non-invasive thyroid cancer diagnostic\",\"datePublished\":\"2025-07-15T06:00:00+00:00\",\"dateModified\":\"2025-07-15T14:05:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/\"},\"wordCount\":327,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/07\/Compremium-Device-1180x811-1.jpg\",\"keywords\":[\"Diagnostic\",\"Digital Health\",\"Healthcare\",\"Oncology\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/\",\"url\":\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/\",\"name\":\"Compremium launches study for thyroid cancer diagnostic | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/07\/Compremium-Device-1180x811-1.jpg\",\"datePublished\":\"2025-07-15T06:00:00+00:00\",\"dateModified\":\"2025-07-15T14:05:31+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Compremium is testing its compressibility-based device in patients with thyroid nodules to improve diagnostic precision.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/07\/Compremium-Device-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/07\/Compremium-Device-1180x811-1.jpg\",\"width\":2360,\"height\":1622,\"caption\":\"Compremium\u2019s device measures tissue compressibility to distinguish between benign and malignant thyroid nodules. | \u00a9 Compremium\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Compremium launches human study for non-invasive thyroid cancer diagnostic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Compremium launches study for thyroid cancer diagnostic | GGBa","description":"Compremium is testing its compressibility-based device in patients with thyroid nodules to improve diagnostic precision.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/","og_locale":"en_US","og_type":"article","og_title":"Compremium launches study for thyroid cancer diagnostic | GGBa","og_description":"Compremium is testing its compressibility-based device in patients with thyroid nodules to improve diagnostic precision.","og_url":"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-07-15T06:00:00+00:00","article_modified_time":"2025-07-15T14:05:31+00:00","og_image":[{"width":2360,"height":1622,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/07\/Compremium-Device-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Compremium launches human study for non-invasive thyroid cancer diagnostic","datePublished":"2025-07-15T06:00:00+00:00","dateModified":"2025-07-15T14:05:31+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/"},"wordCount":327,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/07\/Compremium-Device-1180x811-1.jpg","keywords":["Diagnostic","Digital Health","Healthcare","Oncology"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/","url":"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/","name":"Compremium launches study for thyroid cancer diagnostic | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/07\/Compremium-Device-1180x811-1.jpg","datePublished":"2025-07-15T06:00:00+00:00","dateModified":"2025-07-15T14:05:31+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Compremium is testing its compressibility-based device in patients with thyroid nodules to improve diagnostic precision.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/07\/Compremium-Device-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/07\/Compremium-Device-1180x811-1.jpg","width":2360,"height":1622,"caption":"Compremium\u2019s device measures tissue compressibility to distinguish between benign and malignant thyroid nodules. | \u00a9 Compremium"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/compremium-launches-human-study-for-non-invasive-thyroid-cancer-diagnostic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Compremium launches human study for non-invasive thyroid cancer diagnostic"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/34546","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=34546"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/34546\/revisions"}],"predecessor-version":[{"id":34550,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/34546\/revisions\/34550"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/34547"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=34546"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=34546"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=34546"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}